Alendronate
Brand names,
Alendronate
Analogs
Alendronate
Brand Names Mixture
Alendronate
Chemical_Formula
C4H13NO7P2
Alendronate
RX_link
http://www.rxlist.com/cgi/generic/alendron.htm
Alendronate
fda sheet
Alendronate
msds (material safety sheet)
Alendronate
Synthesis Reference
M. I. Kabachnik et al., Bull. Acad. Sci. USSR,.27, 374 (1978)
Alendronate
Molecular Weight
249.096 g/mol
Alendronate
Melting Point
233 - 235 oC
Alendronate
H2O Solubility
1mg/L
Alendronate
State
Solid
Alendronate
LogP
-3.198
Alendronate
Dosage Forms
Tablets (6.53, 13.05, 45.68, 52.21 or 91.37 mg of alendronate monosodium salt trihydrate)
Alendronate
Indication
For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women.
Alendronate
Pharmacology
Alendronate, a second-generation bisphosphonate is the first member of a group of drugs which strengthens bone. Alendronate is used to reduce hypercalcemia in tumor-induced bone disease, to treat corticosteroid-induced osteoporosis and Paget's disease, and to prevent osteoporosis in postmenopausal women.
Alendronate
Absorption
Relative to an intravenous (IV) reference dose, the mean oral bioavailability of alendronate in women was 0.7% for doses ranging from 5 to 40 mg when administered after an overnight fast and two hours before a standardized breakfast. Oral bioavailability of the 10 mg tablet in men (0.59%) was similar to that in women (0.78%) when administered after an overnight fast and 2 hours before breakfast.
Alendronate
side effects and Toxicity
Alendronate can damage the esophagus both by toxicity from the medication itself and by nonspecific irritation secondary to contact between the pill and the esophageal mucosa, similar to other cases of "pill esophagitis."
Alendronate
Patient Information
Alendronate
Organisms Affected
Humans and other mammals